First Time Loading...
I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 1.44 USD 3.6% Market Closed
Updated: May 29, 2024

Immuneering Corp
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Immuneering Corp
Accounts Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
I
Immuneering Corp
NASDAQ:IMRX
Accounts Receivables
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accounts Receivables
$11.9B
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Accounts Receivables
$4.7B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Accounts Receivables
$6.8B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accounts Receivables
$1.8B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
40%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accounts Receivables
$5.2B
CAGR 3-Years
8%
CAGR 5-Years
18%
CAGR 10-Years
17%

See Also

What is Immuneering Corp's Accounts Receivables?
Accounts Receivables
0 USD

Based on the financial report for Dec 31, 2023, Immuneering Corp's Accounts Receivables amounts to 0 USD.